Nov 22 (Reuters) - Halozyme Therapeutics ( HALO ) said
on Friday it had withdrawn its proposal to acquire Evotec SE
for 2 billion euros ($2.09 billion) after the German
drug developer was unwilling to engage in discussions.
($1 = 0.9587 euros)
(Reporting by Sriparna Roy in Bengaluru; Editing by Devika
Syamnath)